307 related articles for article (PubMed ID: 2525113)
1. Activation and binding of opsonic fragments of C3 on encapsulated Cryptococcus neoformans by using an alternative complement pathway reconstituted from six isolated proteins.
Kozel TR; Wilson MA; Pfrommer GS; Schlageter AM
Infect Immun; 1989 Jul; 57(7):1922-7. PubMed ID: 2525113
[TBL] [Abstract][Full Text] [Related]
2. Activation of the complement system by Cryptococcus neoformans leads to binding of iC3b to the yeast.
Kozel TR; Pfrommer GS
Infect Immun; 1986 Apr; 52(1):1-5. PubMed ID: 3514450
[TBL] [Abstract][Full Text] [Related]
3. Strain variation in phagocytosis of Cryptococcus neoformans: dissociation of susceptibility to phagocytosis from activation and binding of opsonic fragments of C3.
Kozel TR; Pfrommer GS; Guerlain AS; Highison BA; Highison GJ
Infect Immun; 1988 Nov; 56(11):2794-800. PubMed ID: 3049374
[TBL] [Abstract][Full Text] [Related]
4. Role of the capsule in phagocytosis of Cryptococcus neoformans.
Kozel TR; Pfrommer GS; Guerlain AS; Highison BA; Highison GJ
Rev Infect Dis; 1988; 10 Suppl 2():S436-9. PubMed ID: 3055212
[TBL] [Abstract][Full Text] [Related]
5. Early events in initiation of alternative complement pathway activation by the capsule of Cryptococcus neoformans.
Kozel TR; Wilson MA; Murphy JW
Infect Immun; 1991 Sep; 59(9):3101-10. PubMed ID: 1831795
[TBL] [Abstract][Full Text] [Related]
6. Accelerated decay of C3b to iC3b when C3b is bound to the Cryptococcus neoformans capsule.
Pfrommer GS; Dickens SM; Wilson MA; Young BJ; Kozel TR
Infect Immun; 1993 Oct; 61(10):4360-6. PubMed ID: 8406826
[TBL] [Abstract][Full Text] [Related]
7. Activation and binding of C3 by Candida albicans.
Kozel TR; Brown RR; Pfrommer GS
Infect Immun; 1987 Aug; 55(8):1890-4. PubMed ID: 3301679
[TBL] [Abstract][Full Text] [Related]
8. Contribution of antibody in normal human serum to early deposition of C3 onto encapsulated and nonencapsulated Cryptococcus neoformans.
Wilson MA; Kozel TR
Infect Immun; 1992 Mar; 60(3):754-61. PubMed ID: 1541548
[TBL] [Abstract][Full Text] [Related]
9. Activation, binding, and processing of complement component 3 (C3) by Blastomyces dermatitidis.
Zhang MX; Klein B
Infect Immun; 1997 May; 65(5):1849-55. PubMed ID: 9125571
[TBL] [Abstract][Full Text] [Related]
10. Localization on encapsulated Cryptococcus neoformans of serum components opsonic for phagocytosis by macrophages and neutrophils.
Kozel TR; Highison B; Stratton CJ
Infect Immun; 1984 Feb; 43(2):574-9. PubMed ID: 6363293
[TBL] [Abstract][Full Text] [Related]
11. Activation of the complement system by the capsule of Cryptococcus neoformans.
Kozel TR
Curr Top Med Mycol; 1993; 5():1-26. PubMed ID: 8242797
[TBL] [Abstract][Full Text] [Related]
12. Effects of strain variation, serotype, and structural modification on kinetics for activation and binding of C3 to Cryptococcus neoformans.
Young BJ; Kozel TR
Infect Immun; 1993 Jul; 61(7):2966-72. PubMed ID: 8514401
[TBL] [Abstract][Full Text] [Related]
13. Opsonization of encapsulated Cryptococcus neoformans by specific anticapsular antibody.
Kozel TR; Follette JL
Infect Immun; 1981 Mar; 31(3):978-84. PubMed ID: 7014468
[TBL] [Abstract][Full Text] [Related]
14. Opsonization of Cryptococcus neoformans by human immunoglobulin G: role of immunoglobulin G in phagocytosis by macrophages.
Kozel TR; McGaw TG
Infect Immun; 1979 Jul; 25(1):255-61. PubMed ID: 383614
[TBL] [Abstract][Full Text] [Related]
15. Kinetic analysis of the amplification phase for activation and binding of C3 to encapsulated and nonencapsulated Cryptococcus neoformans.
Kozel TR; Wilson MA; Welch WH
Infect Immun; 1992 Aug; 60(8):3122-7. PubMed ID: 1639481
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of C3 by a casein kinase released from activated human platelets increases opsonization of immune complexes and binding to complement receptor type 1.
Nilsson-Ekdahl K; Nilsson B
Eur J Immunol; 2001 Apr; 31(4):1047-54. PubMed ID: 11298329
[TBL] [Abstract][Full Text] [Related]
17. Influence of opsonization conditions on C3 deposition and phagocyte binding of large- and small-capsule Cryptococcus neoformans cells.
Kozel TR; Tabuni A; Young BJ; Levitz SM
Infect Immun; 1996 Jun; 64(6):2336-8. PubMed ID: 8675346
[TBL] [Abstract][Full Text] [Related]
18. Role of serum factors in the phagocytosis of weakly or heavily encapsulated Cryptococcus neoformans strains by guinea pig peripheral blood leukocytes.
Ikeda R; Shinoda T; Kagaya K; Fukazawa Y
Microbiol Immunol; 1984; 28(1):51-61. PubMed ID: 6374392
[TBL] [Abstract][Full Text] [Related]
19. Opsonization of Cryptococcus neoformans by human immunoglobulin G: masking of immunoglobulin G by cryptococcal polysaccharide.
McGaw TG; Kozel TR
Infect Immun; 1979 Jul; 25(1):262-7. PubMed ID: 383615
[TBL] [Abstract][Full Text] [Related]
20. Activated neutrophils exhibit enhanced phagocytosis of Cryptococcus neoformans opsonized with normal human serum.
Kozel TR; Pfrommer GS; Redelman D
Clin Exp Immunol; 1987 Oct; 70(1):238-46. PubMed ID: 2961491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
